Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 215

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology

Ajani, Jaffer A., D’Amico, Thomas A., Bentrem, David J., Corvera, Carlos U., Das, Prajnan, Enzinger, Peter C., Enzler, Thomas, Gerdes, Hans, Gibson, Michael K., Grierson, Patrick, Gupta, Garima, Hofstetter, Wayne L., Ilson, David H., Jalal, Shadia, Kim, Sunnie, Kleinberg, Lawrence R., Klempner, Samuel, Lacy, Jill, Lee, Byrne, Licciardi, Frank, Lloyd, Shane, Ly, Quan P., Matsukuma, Karen, McNamara, Michael, Merkow, Ryan P., Miller, Aaron M., Mukherjee, Sarbajit, Mulcahy, Mary F., Perry, Kyle A., Pimiento, Jose M., Reddi, Deepti M., Reznik, Scott, Roses, Robert E., Strong, Vivian E., Su, Stacey, Uboha, Nataliya, Wainberg, Zev A., Willett, Christopher G., Woo, Yanghee, Yoon, Harry H., McMillian, Nicole R., Stein, MaryElizabeth · 2025 · Journal of the National Comprehensive Cancer Network

Abstract

Gastric cancer is the fifth leading cause of cancer-related deaths worldwide. Over 95% of gastric cancers are adenocarcinomas, which are typically classified based on anatomic location and histologic type. Gastric cancer generally carries a poor prognosis because it is often diagnosed at an advanced stage. Systemic therapy can provide palliation, improve survival, and enhance the quality of life in patients with locally advanced or metastatic disease. The implementation of biomarker testing has had a significant impact on clinical practice and patient care. Targeted therapies have demonstrated encouraging results in clinical trials for the treatment of patients with locally advanced or metastatic disease. This selection from the NCCN Clinical Practice Guidelines in Oncology for Gastric Cancer highlights recommendations for biomarker testing and discusses updates for the treatment of advanced disease, including peritoneal carcinoma as only disease and unresectable locally advanced, recurrent, or metastatic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.6004/jnccn.2025.0022

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Metadata

Authors
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Corvera, C. U., Das, P., Enzinger, P. C., Enzler, T., Gerdes, H., Gibson, M. K., Grierson, P., Gupta, G., Hofstetter, W. L., Ilson, D. H., Jalal, S., Kim, S., Kleinberg, L. R., Klempner, S., Lacy, J., Lee, B., Licciardi, F., Lloyd, S., Ly, Q. P., Matsukuma, K., McNamara, M., Merkow, R. P., Miller, A. M., Mukherjee, S., Mulcahy, M. F., Perry, K. A., Pimiento, J. M., Reddi, D. M., Reznik, S., Roses, R. E., Strong, V. E., Su, S., Uboha, N., Wainberg, Z. A., Willett, C. G., Woo, Y., Yoon, H. H., McMillian, N. R., & Stein, M.
Venue
Journal of the National Comprehensive Cancer Network
Published
2025-05
Volume
23
Issue
5
Pages
169-191
ISSN
  • 1540-1405 (ISSN-L)
  • 1540-1413
OpenAlex
W4410208838
Cited by
215
References
12
FWCI
127.40
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. https://app.cochat.ai/papers/10.6004/jnccn.2025.0022
The paper
Ajani, J. A., D’Amico, T. A., Bentrem, D. J., Corvera, C. U., Das, P., Enzinger, P. C., Enzler, T., Gerdes, H., Gibson, M. K., Grierson, P., Gupta, G., Hofstetter, W. L., Ilson, D. H., Jalal, S., Kim, S., Kleinberg, L. R., Klempner, S., Lacy, J., Lee, B., . . . Stein, M. (2025). Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology. Journal of the National Comprehensive Cancer Network. https://doi.org/10.6004/jnccn.2025.0022

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.